Tachykinins and the control of prolactin secretion

Peptides

Volumn 27, Issue 11, 2006, Pages 3007-3019

  Debeljuk, Luciano ^a   Lasaga, Mercedes ^b  

^a SOUTHERN ILLINOIS UNIVERSITY   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Anterior pituitary; Hypothalamus; Neurotransmitters; Prolactin; Tachykinins

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; NEUROHORMONE; NEUROPEPTIDE; NEUROTRANSMITTER; OXYTOCIN; PROLACTIN; PROTIRELIN; SEROTONIN; TACHYKININ; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

4 AMINOBUTYRIC ACID RELEASE; BRAIN FUNCTION; DOPAMINE RELEASE; HORMONE ACTION; HORMONE RELEASE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; REPRODUCTION; REVIEW; STATISTICAL SIGNIFICANCE; STRESS;

HUMANS; HYPOTHALAMUS; NEUROTRANSMITTER AGENTS; PITUITARY GLAND; PROLACTIN; TACHYKININS;

EID: 33750086363     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.07.010     Document Type: Review

References (185)

1. Abbud R., and Smith M.S. Altered luteinizing hormone and prolactin responses to excitatory amino acids during lactation. Neuroendocrinology 58 (1993) 454-464
2. Afione S., Debeljuk L., Seilicovich A., Pisera D., Lasaga M., Díaz M.C., et al. Substance P affects the GABAergic system in the hypothalamo-pituitary axis. Peptides 11 (1990) 1065-1068
3. Afione S., Duvilanski B., Seilicovich A., Lasaga M., Díaz M.C., and Debeljuk L. Effects of serotonin on the hypothalamic-pituitary GABAergic system. Brain Res Bull 25 (1990) 245-249
4. Andrews W.V., and Conn P.M. Gonadotropin-releasing hormone stimulates mass changes in phosphoinositides and diacylglycerol accumulation in purified gonadotrope cell cultures. Endocrinology 118 (1986) 1148-1458
5. Apud J.A., Cocchi D., Locatelli V., Masotto C., Muller E.E., and Racagni G. Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic system. Psychoneuroendocrinology 14 (1989) 3-17
6. Arey B.J., and Freeman M.E. Hypothalamic factors involved in the endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 124 (1989) 878-883
7. Arey B.J., and Freeman M.E. Oxytocin, vasoactive intestinal peptide and serotonin regulate the mating-induced surges of prolactin secretion in the rat. Endocrinology 126 (1990) 279-284
8. Arey B.J., and Freeman M.E. Activity of oxytocinergic neurons in the paraventricular nucleus mirrors the periodicity of the endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 130 (1992) 126-132
9. Arey B.J., Averill R.L., and Freeman M.E. A sex-specific endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology 124 (1989) 119-123
10. Arisawa M., Snyder G.D., Yu W.H., De Palatis L.R., Ho R.H., and McCann S.M. Physiologically significant inhibitory hypothalamic action of substance P on prolactin release in the male rat. Neuroendocrinology 52 (1990) 22-27
11. Arita J., Kojima Y., Yamamoto I., Mazawa S., and Kimura F. Somatotropes and thyrotropes in the rat anterior pituitary gland cosecrete substance P: analysis by the sandwich cell immunoblot assay. Neuroendocrinology 60 (1994) 567-574
12. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT 1A, 5-HT 2A and 5-HT 2c receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res 73 (1996) 277-280
13. Bailey C.P., Maubach K.A., and Jones R.S. Neurokinin-1 receptors in the rat nucleus tractus solitarius: pre- and postsynaptic modulation of glutamate and GABA release. Neuroscience 127 (2004) 467-479
14. Baruch P., Artaud F., Godeheu G., Barbeito L., Glowinski J., Cheramy A., et al. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 25 (1998) 889-898
15. Bath G.H., Mahesh V.B., Chu Z.W., Chorich L.P., Zamorano P.L., and Brann D.W. Localization of the N-methyl-d-aspartate R1 receptor subunit in specific anterior pituitary hormone cell types of the female rat. Neuroendocrinology 62 (1995) 178-186
16. Bealer S.L., and Flynn F.W. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine. Exp Neurol 184 (2003) 1027-1033
17. Ben-Jonathan N., and Liu J.-W. Pituitary lactotrophs: endocrine, paracrine, juxtacrine, and autocrine interactions. Trends Endocrinol Metab 3 (1992) 254-258
18. Benson G.K., and Cowie A.T. Lactation in the rat after hypophyseal posterior lobectomy. J Endocrinol 14 (1956) 54-65
19. Bethea C.L., and Neill J.D. Prolactin secretion after cervical stimulation of rats maintained in constant dark or constant light. Endocrinology 104 (1979) 870-876
20. Bittencourt J.C., Benoit R., and Sawchenko P.E. Distribution and origins of substance P-immunoreactive projections to the paraventricular and supraoptic nuclei: partial overlap with ascending catecholaminergic projections. J Chem Neuroanat 4 (1991) 63-78
21. Block M.L., Li G., Qin L., Wu X., Pei Z., Wang T., et al. Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 20 (2006) 251-258
22. Bolam J.P., and Smith Y. The GABA and substance P input to dopaminergic neurons in the substantia nigra of the rat. Brain Res 529 (1990) 57-78
23. Brann D.W., and Mahesh V.B. Endogenous excitatory amino acid involvement in the preovulatory and steroid-induced surge of gonadotropins in the female rat. Endocrinology 128 (1991) 1541-1547
24. Brann D.W., Ping L., and Mahesh V.B. Possible role of non-NMDA receptor-mediated neurotransmission in steroid-induced and preovulatory gonadotropin surges in the rat. Mol Cell Neurosci 4 (1993) 292-297
25. Bregonzio C., Navarro C.E., and Donoso A.O. NMDA receptor antagonists block stress-induced prolactin release in female rats at estrus. Eur J Pharm 350 (1998) 259-265
26. Brownstein M.J., Eskay R.L., and Palkovits M. Thyrotropin releasing hormone in the median eminence is in processes of paraventricular nuclelus neurons. Neuropeptides 2 (1982) 197-201
27. Brown E., Roth K., and Krause J. Sexually dimorphic distribution of substance P in specific anterior pituitary cell populations. Proc Natl Acad Sci USA 88 (1990) 1222-1226
28. Brownstein M.J., Eskay R.L., and Palkovits M. Thyrotropin releasing hormone in the median eminence is in processes of paraventricular nucleus neurons. Neuropeptides 2 (1982) 197-201
29. Byrne J.M., Jones P.M., Hill S.F., Bennet W.M., Ghatei M.A., and Bloom S.R. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary. J Clin Endocrinol Metab 75 (1992) 983-987
30. Calogero A.E., Bagdy G., Burrello N., Polosa P., and D'Agata R. Role for serotonin3 receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures. Eur J Endocrinol 133 (1995) 251-254
31. Caruso C., Bottino M.C., Pampillo M., Pisera D., Jaita G., Duvilanski B., et al. Glutamate induces apoptosis in anterior pituitary cells through group II metabotropic glutamate receptor activation. Endocrinology 145 (2004) 4677-4684
32. Caruso C., Durand D., Watanobe H., and Lasaga M. NMDA and group I metabotropic glutamate receptors activation modulates substance P release from the arcuate nucleus and median eminence. Neurosci Lett 393 (2006) 60-64
33. Chen L.W., Yung K.K., and Chan Y.S. Neurokinin peptides and neurokinin receptors as potential therapeutic intervention targets of basal ganglia in the prevention and treatment of Parkinson's disease. Curr Drug Targets 5 (2004) 197-206
34. Chihara K., Arimura A., Coy D.H., and Schally A.V. Studies on the interaction of endorphins, substance P, and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology 102 (1978) 281-290
35. Clarke I., Jessop D., Millar R., Morris M., Bloom S., Lightman S., et al. Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep. Neuroendocrinology 57 (1993) 765-775
36. Coiro V., Volpi R., Capretti L., Caizza A., Caffarri G., Rossi G., et al. Intravenously infused substance P is unable to change basal and TRH-stimulated PRL secretion in normal men. Horm Res 39 (1993) 73-76
37. Debeljuk L., Bandera R., and Bartke A. Effect of a non-peptide NK-2 tachykinin receptor antagonist on LH, FSH and prolactin release by hemipituitaries in vitro. J Physiol Pharm 48 (1997) 461-478
38. Debeljuk L., and Lasaga M.I. Modulation of the hypothalamo-pituitary-gonadal axis and the pineal gland by neurokinin A, neuropeptide K and neuropeptide γ. Peptides 20 (1999) 285-299
39. Debeljuk L., Lasaga M.I., Afione S., Duvilanski B., and Diaz M.C. Effect of passive immunization against substance P in rats with hyperprolactinemia. Peptides 9 (1988) 933-936
40. Debeljuk L., Lasaga M., Horvath J., Duvilanski B., Seilicovich A., and Diaz M.C. Effect of an anti-substance P serum on prolactin and gonadotropins in hyperprolactinemic rats. Regul Peptides 19 (1987) 91-98
41. Dees W.L., Skelley C.W., and Kozlowski G.P. Central effects of an antagonist and an antiserum to substance P on serum gonadotropins and prolactin secretion. Life Sci 37 (1985) 1627-1631
42. De Laurentiis A., Pisera D., Duvilanski B., Rettori V., Lasaga M., and Seilicovich A. Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by stimulating nitric oxide synthase. Brain Res Bull 53 (2000) 325-330
43. Deschamps K., and Couture R. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Br J Pharm 145 (2005) 712-727
44. Ding Y.Q., Lu B.Z., Guan Z.L., Wang D.S., Xu J.Q., Li J.H., et al. Neurokinin B receptor (NK-3)-containing neurons in the paraventricular and supraoptic nuclei of the rat hypothalamus synthesize vasopressin and express Fos following intravenous injection of hypertonic saline. Neuroscience 91 (1999) 1077-1085
45. Ding Y.Q., Shi J., Su L.Y., Xu J.Q., Su C.J., Guo X.E., et al. Intracerebro-ventricular injection of senktide-induced Fos expression in vasopressin-containing hypothalamic meurons in the rat. Brain Res 882 (2000) 95-102
46. Dohanics J., Smith M.S., Blackburn R.E., and Verbalis J.G. Osmotic inhibition of prolactin secretion in rats. J Neuroendocrinol 6 (1994) 291-298
47. Dudas B., and Merchenthaler I. Three-dimensional representation of the neurotransmitter systems of the human hypothalamus: inputs of the gonadotrophin hormone-releasing hormone neuronal system. J Neuroendocrinol 18 (2006) 79-95
48. Duvilanski B., Pisera D., Seilicovich A., Diaz M.C., Lasaga M., Isovich E., et al. Interaction between substance P and TRH in the control of prolactin release. J Endocrinol 166 (2000) 373-380
49. Eckstein N., Wehrenberg W.B., Louis K., Carmel P.W., Zimmermann E.A., Frantz A.G., et al. Effects of substance P on anterior pituitary secretion in the female rhesus monkey. Neuroendocrinology 31 (1980) 338-342
50. Enjalbert A., Ruberg M., Arancibia S., Fiore L., Priam M., and Kordon C. Independent inhibition of prolactin secretion by dopamine and gamma-aminobutyric acid in vitro. Endocrinology 105 (1979) 823-826
51. Esquifino A.I., Arce A., Debeljuk L., and Bartke A. Effects of immunoneutralization of substance P on hypothalamic neurotransmitters in normal mice and in transgenic mice expressing bovine growth hormone. Proc Soc Exp Biol Med 218 (1998) 68-75
52. Fessler R.G., Deyo S.N., Meltzer H.Y., and Miller R.J. Evidence that the medial and dorsal raphe nuclei mediate serotonergically-induced increases in prolactin release from the pituitary. Brain Res 299 (1984) 231-237
53. Freeman M.E., Kanyicska B., Lerant A., and Nagy G. Prolactin: structure, function and regulation of secretion. Physiol Rev 80 (2000) 1523-1631
54. Furuta T., Koyano K., Tomioka R., Yanagawa Y., and Kaneko T. GABAergic basal forebrain neurons that express receptor for neurokinin B and send axons to the cerebral cortex. J Comp Neurol 473 (2004) 43-58
55. Gay V.L., and Plant T.M. Sustained intermittent release of gonadotropin-releasing hormone in the prepubertal male rhesus monkey induced by N-methyl-dl-aspartic acid. Endocrinology 120 (1987) 2289-2296
56. Gobbi G., and Blier P. Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides 26 (2005) 1383-1393
57. Goffin V., Binart N., Touraine P., and Kelly P.A. Prolactin: the new biology of an old hormone. Ann Rev Physiol 64 (2002) 47-67
58. Grandison L., and Guidotti A. Gamma-aminobutyric acid receptor function in rat anterior pituitary: evidence for control of prolactin release. Endocrinology 105 (1979) 754-759
59. Gullner H.G., Yajima H., Herbert D., and Owen W.W. Growth hormone, prolactin and FSH release by the tachykinin dodecapeptide kassinin in the rat. Arch Int Pharmacodyn 256 (1982) 4-9
60. Haddjeri N., and Blier P. Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons. Neuroreport 11 (2000) 1323-1327
61. Hagen T.C., Arnaout M.A., Scherzer W.J., Martinson D.R., and Garthwaite A.L. Antisera to vasoactive intestinal polypeptide inhibit basal prolactin release from dispersed anterior pituitary cells. Neuroendocrinology 43 (1986) 641-645
62. Haisenleder D.J., Gala R.R., and Lawson D.M. Comparison of the effects of suckling or transient dopamine antagonism on thyrotropin-releasing hormone and suckling induced prolactin release in lactating rats. Life Sci 39 (1986) 659-664
63. Haisenleder D.J., Moy J.A., Gala R.R., and Lawson D.M. Effect of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pregnant rats. Endocrinology 119 (1986) 1980-1988
64. Haisenleder D.J., Moy J.A., Gala R.R., and Lawson D.M. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats. Proc Soc Exp Biol Med 187 (1988) 341-349
65. Hamada T., Yamanouchi S., Watanabe A., Shibata S., and Watanabe S. Involvement of glutamate release in substance P-induced phase delays of suprachiasmatic neuron activity rhythm in vitro. Brain Res 836 (1999) 190-193
66. Herniksen J.S., Saermark T., Vilhardt H., and Mau S.E. Tachykinins induce secretion of prolactin from perifused rat anterior pituitary cells by interaction with two different binding sites. J Recept Signal Trans Res 15 (1995) 529-541
67. Houben H., and Denef C. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro. Peptides 14 (1993) 109-115
68. Howe H.E., Somponpun S.J., and Sladek C.D. Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons. J Neurosci 24 (2004) 10103-10110
69. Hrabovszky E., Turi G.F., Kallo I., and Liposits Z. Expression of vesicular glutamate transporter-2 in gonadotropin-releasing hormone neurons of the adult male rat. Endocrinology 145 (2004) 4018-4021
70. Hrabovszky E., Turi G.F., and Liposits Z. Presence of vesicular glutamate transporter-2 in hypophysiotropic somatostatin but not growth hormone-releasing hormone neurons of the male rat. Eur J Neurosci 21 (2005) 2120-2126
71. Hrabovszky E., Wittmann G., Turi G.F., Liposits Z., and Fekete C. Hypophysiotropic thyrotropin-releasing hormone and corticotropin-releasing hormone neurons of the rat contain vesicular glutamate transporter-2. Endocrinology 146 (2005) 346-347
72. Hubert G.W., and Kuhar M.J. Colocalization of CART with substance P but not enkephalin in the rat nucleus accumbens. Brain Res 1050 (2005) 8-14
73. Hutcherson L., and Roberts R.C. The immunocytochemical localization of substance P in the human striatum: a postmortem ultrastructural study. Synapse 57 (2005) 191-201
74. Hyde J.F., North W.G., and Ben-Jonathan N. The vasopressin-associated glycopeptide is not a prolactin-releasing factor: studies with lactating Brattleboro rats. Endocrinology 25 (1989) 35-40
75. Isovich E., Díaz M.C., Lasaga M., Pisera D., Zambruno C., Theas M.S., et al. Involvement of hypothalamic substance P in the effect of prolactin on dopamine release. Neuroreport 5 (1994) 1752-1754
76. Jessop D.S., Chowdrey H.S., Larsen P.J., and Lightman S.L. Substance P: multifunctional peptide in the hypothalamo-pituitary system?. J Endocrinol 132 (1992) 331-337
77. Jones P.M., ÓHalloran D.J., Ghatei M.A., Domin J., and Bloom S.R. The influence of adrenal hormone status on neuroendocrine peptides in the rat anterior pituitary gland. J Endocrinol 127 (1990) 437-444
78. Johnston C.A., and Negro-Vilar A. Role of oxytocin on prolactin secretion during proestrus and in different physiological or pharmacological paradigms. Endocrinology 122 (1988) 341-350
79. Juszczak M. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Neuro Endocrinol Lett 26 (2005) 367-372
80. Juszczak M., and Stempniak B. Melatonin inhibits the substance P-induced secretion of vasopressin and oxytocin from the rat hypothalamo-neurohypophysial system: in vitro studies. Brain Res Bull 59 (2003) 393-397
81. Kapoor J.R., and Sladek C.D. Substance P NPY differentially potentiate ATP and adrenergic stimulated vasopressin and oxytocin release. Am J Physiol Regul Integr Comp Physiol 280 (2001) R69-R78
82. Kato Y., Chihara K., Ohgo S., Iwasaki Y., Abe H., and Imura H. Growth hormone and prolactin release by substance P in rats. Life Sci 19 (1976) 441-446
83. Kato Y., Nakai Y., Imura H., Chihara K., and Ogo S. Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. J Clin Endocrinol Metab 38 (1974) 695-697
84. Kawakami M., Arita J., and Yoshioka E. Loss of estrogen-induced daily surges of prolactin and gonadotropins by suprachiasmatic nucleus lesions in ovariectomized rats. Endocrinology 106 (1980) 1087-1092
85. Kerdelhue B., Tartar A., Lenoir V., El Abed A., Hublau P., and Millar R.P. Binding studies of substance P anterior pituitary binding sites: changes in substance P binding sites during the rat estrous cycle. Regul Peptides 10 (1985) 133-143
86. Kim D.Y., Kang H.C., Shin H.C., Lee K.J., Yoon Y.W., Han H.C., et al. Substance P plays a critical role in photic resetting of the circadian pacemarker in the rat hypothalamus. J Neurosci 21 (2001) 4026-4031
87. Kiss J.Z., Kanyicska B., and Nagy G.M. The hypothalamic paraventricular nucleus has a pivotal role in regulation of prolactin release in lactating rats. Endocrinology 119 (1986) 870-873
88. Kizer J.S., Zivin J.A., Jacobowitz D.M., and Kopin I.J. The nyctohemeral rhythm of plasma prolactin: effects of ganglionectomy, pinealectomy, constant light, constant darkness or 6-OH-dopamine administration. Endocrinology 96 (1975) 1230-1240
89. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., and Matowe W.C. Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro. Eur J Neurosci 18 (2003) 303-311
90. Kumar V., Lincoln G.A., and Tortonese D.J. Effects of excitatory amino acid receptor agonists and antagonists on the secretion of melatonin, luteinizing hormone and prolactin in the ram. J Neuroendocrinol 5 (1993) 649-654
91. Lamberts S.W., and MacLeod R.M. The interaction of the serotonergic and dopaminergic systems on prolactin secretion in the rat. The mechanism of action of the "specific" serotonin receptor antagonist, methysergide. Endocrinology 103 (1978) 287-295
92. Lamberts S.W., and MacLeod R.M. Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 70 (1990) 279-318
93. Larsen P.J., Mikkelsen J.D., Mau S., and Saermark T. Binding and internalization of a iodinated substance P analog by cultured anterior pituitary cells. Mol Cell Endocrinol 65 (1989) 91-101
94. Larsen P.J., Saermark T., and Mau S.E. Binding of a iodinated substance P analogue to cultured anterior pituitary prolactin- and luteinizing hormone-containing cells. J Histochem Cytochem 40 (1992) 487-493
95. Léger L., Gay N., and Cespuglio R. Neurokinin NK1- and NK3-immunoreactive neurons in serotonergic cell groups in the rat brain. Neuroscience Lett 323 (2002) 146-150
96. Lin J.Y., Li C.S., and Pan J.T. Effects of various neuroactive substances on single-unit activities of hypothalamic arcuate neurons in brain slices. Brain Res Bull 31 (1993) 587-594
97. Lindefors N., Brodin E., Tossman U., Segovia J., and Ungerstedt U. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation. Exp Brain Res 74 (1989) 527-534
98. Liu L., and Burcher E. Tachykinin peptides and receptors: putting amphibians into perspective. Peptides 26 (2005) 1369-1382
99. Liu H., Cao Y., Basbaum A., Mazarati A., Sankar R., and Wasterlain C. Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene. PNAS 96 (1999) 12096-12101
100. Liu R., Ding Y., and Aghajanian G.K. Neurokinins activate local glutamatergic inputs to serotonergic neurons of the dorsal raphe nucleus. Neuropsychopharmacology 27 (2002) 329-340
101. Liu S. Peptidergic innervation in pars distalis of the human anterior pituitary. Brain Res 1008 (2004) 61-68
102. Ljungdahl A., Hokfelt T., and Nilsson G. Distribution of substance P-like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals. Neuroscience 3 (1978) 861-943
103. Lumpkin M.D., Samson W.K., and McCann S.M. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Endocrinology 112 (1983) 1711-1718
104. Ma Q.P., and Bleasdale C. Modulation of brain stem monoamines and gamma-aminobutyric acid by NK1 receptors in rats. Neuroreport 13 (2002) 1809-1812
105. Maeno H., Kiyama H., and Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Brain Res Mol Brain Res 18 (1993) 43-58
106. Maggio J. Tachykinins. Ann. Rev Neurosci 11 (1988) 13-28
107. Magoul R., Dubourg P., Benjelloun W., and Tramu G. Synaptic inputs of tachykinin-containing nerve terminals to target tyrosine-hydroxylase-, beta-endorphin- and neuropeptide Y-producing neurons of the arcuate nucleus. Double pre-embedding immunocytochemical study in the rat. J Chem Neuroanat 6 (1993) 419-429
108. Makara G.B., Kakucska I., Lenoir V., Kerdelhue B., and Palkovits M. A substance P-containing hypothalamic neuronal system projects to the median eminence. Brain Res 374 (1986) 399-401
109. 2+/protein kinase C pathway 1. Neuroendocrinology 47 (1988) 38-45
110. Martinez De La Escalera G., Porter B.W., Martin T.F.J., and Weiner R.I. Dopamine withdrawal and addition of thyrotropin-releasing hormone stimulate membrane translocation of protein kinase-C and phosphorylation of an endogenous 80 K substrate in enriched lactotrophs. Endocrinology 125 (1989) 1168-1173
111. Martínez De La Escalera G., and Weiner R.I. Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. Endocr Rev 13 (1992) 241-255
112. Marvizon J.C.G., Wang X., Matsuka Y., Neubert J.K., and Spigelman I. Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalization in the rat spinal cord. Neuroscience 118 (2003) 535-545
113. Mau S.E. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses. J Mol Endocrinol 18 (1997) 181-191
114. Mau S.E., Larsen P.J., Mikkelsen J.A., and Saermark T. Substance P and related tachykinins induce receptor-mediated hydrolysis of polyphosphoinositides in the rat anterior pituitary. Mol Cell Endocrinol 69 (1990) 69-78
115. Mau S.E., Saermark T., and Vilhardt H. Cross-talk between cellular signaling pathways activated by substance P and vasoactive intestinal peptide in rat lactotroph-enriched pituitary cell cultures. Endocrinology 138 (1997) 1704-1711
116. 2+ in individual rat pituitary lactotrophs, somatotrophs, and gonadotrophs. Mol Cell Endocrinol 126 (1997) 193-201
117. Maubach K.A., Cody C., and Jones R.S. Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition. Neuroscience 83 (1998) 1047-1062
118. Meister B., and Hokfelt T. Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 2 (1988) 585-605
119. Michelot R., Leviel V., Giorguieff-Chesselet M.F., Cheramy A., and Glowinski J. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways. Life Sci 24 (1979) 715-723
120. Mikkelsen J.D., Larsen P.J., Moller M., Vilhardt H., and Saermark T. Substance P in the median eminence and pituitary of the rat: demonstration of immunoreactive fibers and specific binding sites. Neuroendocrinology 50 (1989) 100-108
121. Mileusnic D., Lee J.M., Magnuson D.J., Hejna M.J., Krause J.E., Lorens J.B., et al. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 89 (1999) 1269-1290
122. Mogg R.J., and Samson W.K. Interactions of dopaminergic and peptidergic factors in the control of prolactin release. Endocrinology 126 (1990) 728-735
123. Mormede P., Vincent J.-D., and Kerdelhué B. Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved. Life Sci 39 (1986) 1737-1745
124. Muir J.L., and Pfister H.P. Influence of exogenously administred oxytocin on the corticosterone and prolactin response to psychologic stress. Pharm Biochem Behav 29 (1988) 699-703
125. Nagy G.M., Bodnár I., Bánky Z., and Halász B. Control of prolactin secretion by excitatory amino acids. Endocrine 28 (2005) 303-308
126. Nagy G.M., Gorcs T.J., and Halasz B. Attenuation of the suckling-induced prolactin release and the high afternoon oscillations of plasma prolactin secretion of lactating rats by antiserum to vasopressin. Neuroendocrinology 54 (1991) 566-570
127. Nagy G., Mulchahey J.J., Smyth D.G., and Neill J.D. The glycopeptide moiety of vasopressin-neurophysin precursor is neurohypophysial prolactin releasing factor. Biochem Biophys Res Commun 151 (1998) 524-529
128. Nakanishi S. Mammalian tachykinin receptors. Ann Rev Neurosci 14 (1991) 123-136
129. Nussdorfer G., and Malendowicz L. Role of VIP, PACAP, and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 19 (1998) 1443-1467
130. ÓHalloran D.J., Jones P.M., Ghatei M.A., and Bloom S.R. Rat anterior pituitary neuropeptides following chronic prolactin manipulation: a combined radioimmunoassay and mRNA study. J Endocrinol 131 (1991) 411-419
131. Ogier R., and Raggenbass M. Action of tachykinins in the rat hyppocampus: modulation of inhibitory synaptic transmission. Eur J Neurosci 17 (2003) 2639-2647
132. Olpe H.R., Heid J., Bittiger H., and Steinmann M.W. Substance P depresses neuronal activity in the rat olfactory bulb in vitro and in vivo: possible mediation via gamma-aminobutyric acid release. Brain Res 412 (1987) 269-274
133. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73 (1993) 229-308
134. Page N.M. Hemokinins and endokinins. Cell Mol Life Sci 61 (2004) 1652-1663
135. Page N.M. New challenges in the study of the mammalian tachykinins. Peptides 26 (2005) 1356-1368
136. Page N.M., Bell N.J., Gardiner S.M., Manyonda I.T., Brayley K.J., Strange P.G., et al. Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci USA 100 (2003) 6245-6250
137. Pampillo M., Theas S., Duvilanski B., Seilikoovich A., and Lasaga M. Effect of ionotropic and metabotropic glutamate agonists and d-aspartate on prolactin release from anterior pituitary cells. Exp Clin Endocrinol Diabetes 110 (2002) 138-144
138. Pan J.-T., and Mai L.-M. Dopamine antagonism does not potentiate the effects of oxytocin and vasopressin on prolactin secretion. Life Sci 47 (1990) 2443-2450
139. Parker S., and Crowley W.R. Stimulation of oxytocin release in the lactating rat by central excitatory amino acid mechanisms: evidence for specific involvement of R,S-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid sensitive glutamate receptors. Endocrinology 133 (1993) 2847-2854
140. Parker D.C., Rossman L.G., and Van Der Laan E.F. Relation of sleep-entrained human prolactin release to REM-nonREM cycles. J Clin Endocrinol Metab 38 (1974) 646-651
141. Picanco-Diniz D., Valenca M.M., Franci C.R., and Antines-Rodrigues J. Role of substance P in the medial preoptic area in the regulation of gonadotropin and prolactin secretion in normal or orchidectomized rats. Neuroendocrinology 51 (1990) 675-682
142. Piggins H.D., Cutler D.J., and Rusak B. Ionophoretically applied substance P activates hamster suprachiasmatic neurons. Brain Res Bull 37 (1995) 475-479
143. Pisera D., Candolfi M., De Laurentiis A., and Seilicovich A. Characterization of tachykinin NK2 receptor in the anterior pituitary gland. Life Sci 73 (2003) 2421-2432
144. Pisera D., Debeljuk L., Seilicovich A., Afione S., Duvilanski B., Diaz M.C., et al. Possible role of neurokinin A in the physiological control of prolactin secretion in rats and hamsters. J Neuroendocrinol 3 (1991) 39-44
145. Pisera D., De Laurentiis A., Duvilanski B., Lasaga M., Díaz M.C., and Seilicovich A. Neurokinin A affects the tubero-hypophyseal gabaergic system. Neuroreport 7 (1996) 2236-2240
146. Pisera D., Theas S., De Laurentiis A., Lasaga M., Duvilanski B., and Seilicovich A. The hormonal status modulates the effect of neurokinin A on prolactin secretion in female rats. J Endocrinol 159 (1998) 389-395
147. Pohl C.R., Lee L.R., and Smith M.S. Qualitative changes in luteinizing hormone and prolactin responses to N-methyl-aspartic acid during lactation in the rat. Endocrinology 124 (1989) 1905-1911
148. Racagni G., Apud J.A., Locatelli V., Cocchi D., Nistico G., Di Giorgio R.M., et al. GABA of CNS origin in the rat anterior pituitary inhibits prolactin secretion. Nature 281 (1979) 575-578
149. Reichlin S. Prolactin and growth hormone secretion in stress. Adv Exp Med Biol 245 (1988) 353-376
150. Rivier C., Brown M., and Vale W. Effect of neurotensin, substance P and morphine sulphate on the secretion of prolactin and growth hormone in the rat. Endocrinology 100 (1977) 751-754
151. Rostene W.H. Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Prog Neurobiol 22 (1984) 103-129
152. Roth K., and Krause J. Substance P is present in a subset of thyrotrophs in the human pituitary. J Clin Endocrinol Metab 71 (1990) 1089-1095
153. Saffroy M., Beaujouan J.C., Torrens Y., Besseyre J., Bergstrom L., and Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides 9 (1988) 227-241
154. Salthun-Lassalle B., Traver S., Hirsch E.C., and Michel P.P. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Mol Pharm 68 (2005) 1214-1224
155. Samson W.K., and Schell D.A. Oxytocin and the anterior pituitary gland. Adv Exp Med Biol 395 (1995) 355-364
156. Samson W.K., Taylor M.M., and Baker J.R. Prolactin-releasing peptides. Regul Peptides 114 (2003) 1-5
157. Sassin J.F., Frantz A.G., Kapen S., and Weitzman E.D. The nocturnal rise of human prolactin is dependent on sleep. J Clin Endocrinol Metab 37 (1973) 436-440
158. Schally A.V., Redding T.W., Arimura A., Dupont A., and Linthicum G.L. Isolation of gamma-amino butyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology 100 (1977) 681-691
159. Selmanoff M. The lateral and medial median eminence: distribution of dopamine, norepinephrine, and luteinizing hormone-releasing hormone and the effect of prolactin on catecholamine turnover. Endocrinology 108 (1981) 1716-1722
160. Severini C., Ciotti T., Mercanti D., Barbato C., and Calissano P. A tachykinin-like factor increases glutamate toxicity in rat cerebellar granule cells. Neuropharmacology 44 (2003) 117-124
161. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharm Rev 54 (2002) 285-322
162. Shirakawa T., and Moore R.Y. Responses of rat suprachiasmatic nucleus neurons to substance P and glutamate in vitro. Brain Res 642 (1994) 213-220
163. Simerly R.B., and Swanson L.W. The distribution of neurotransmitter-specific cells and fibers in the anteroventral periventricular nucleus: implications for the control of gonadotropin secretion in the rat. Brain Res 400 (1987) 11-34
164. Sladek C.D., and Armstrong W.E. Neural pathways subserving osmotic control of vasopressin release. In: Schrier R. (Ed). Vasopressin (1985), Raven, New York 435-441
165. Spitznagel H., Baulmann J., Blume A., Unger T., and Culman J. c-FOS expression in the rat brain in response to substance P and neurokinin B. Brain Res 916 (2001) 11-21
166. Stacey A.E., Woodhall G.L., and Jones R.S.G. Neurokinin-receptor-mediated depolarization of cortical neurons elicits and increase in glutamate release at excitatory synapses. Eur J Neurosci 16 (2002) 1896-1906
167. Tang F.I., Chiu T.H., and Wang Y. Electrochemical studies of the effects of substance P on dopamine terminals in the rat striatum. Exp Neurol 152 (1998) 41-49
168. Tappaz M.L., Brownstein M.J., and Palkovits M. Distribution of glutamate decarboxylase in discrete brain nuclei. Brain Res 108 (1976) 371-379
169. Tappaz M.L., Kakucska I., Paut L., and Makara G.B. Decreased GABAergic innervation of the pituitary intermediate lobe after rostral hypothalamic cuts. Brian Res Bull 17 (1986) 711-716
170. Tejero-Taldo M.I., Chmielinska J.J., Gonzalez G., Mak I.T., and Weglicki W.B. NMDA receptor blockade inhibits cardiac inflammation in the Mg-deficient rat. J Pharm Exp Ther 311 (2004) 8-13
171. Thomas G.B., Cummins J.T., Griffin N., and Clarke I.J. Effect and site of action of hypothalamic neuropeptides on prolactin release in sheep. Neuroendocrinology 48 (1988) 252-257
172. Traczyk W.Z., Pau R.-Y.F., Kaynard A.H., and Spies H.G. Modulatory role of substance P on gonadotropin and prolactin secretion in the rabbit. J Physiol Pharm 43 (1992) 279-298
173. Tsuruo Y., Kawano H., Nishiyama T., Hisano S., and Daikoku S. Substance P-like immunoreactive neurons in the tuberoinfundibular area of rat hypothalamus. Light and electron microscopy. Brain Res 289 (1983) 1-9
174. Van De Kar L.D., and Bethea C.L. Pharmacological evidence that serotonergic stimulation of prolactin secretion is mediated via the dorsal raphe nucleus. Neuroendocrinology 35 (1982) 225-230
175. Vanden Broeck J., Torfs H., Poels J., Van Poyer W., Swinnen E., Ferket K., et al. Tachykinin-like peptides and their receptors. A review. Ann NY Acad Sci 897 (1999) 374-387
176. Vecsernyés M., Krempels K., Toth B.E., Julesz J., Makara G.B., and Nagy G.M. Effect of posterior pituitary denervation (PPD) on prolactin (PRL) and π-melanocyte-stimulating hormone (π-MSH) secretion of lactating rats. Brain Res Bull 43 (1997) 313-319
177. Vijayan E., and McCann S.M. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 105 (1979) 64-68
178. Vincent S.R., Hokfelt T., and Wu J.Y. GABA neuron systems in hypothalamus and the pituitary gland. Immunohistochemical demonstration using antibodies against glutamate decarboxylase. Neuroendocrinology 34 (1982) 117-125
179. Wagner E.J., Moore K.E., and Lookingland K.J. Sexual differences in N-methyl-d-aspartate receptor-mediated regulation of tuberoinfundibular dopaminergic neurons in the rat. Brain Res 611 (1993) 139-146
180. Waldstreicher J., Duffy J.F., Brown E.N., Rogacz S., Allan J.S., and Czeisler C.A. Gender differences in the temporal organization of prolactin (PRL) secretion: evidence for a sleep-independent circadian rhythm of circulating PRL levels-a clinical research center study. J Clin Endocrinol Metab 81 (1996) 1483-1487
181. Winkler A., Papsdorf G., Odarjuk J., Siems W.E., Fickel J., and Melzig M.F. Expression and characterization of the substance P (NK1) receptor in the rat pituitary and AtT20 mouse pituitary tumor cells. Eur J Pharm 291 (1995) 51-55
182. Yao R., Rameshwar P., Donnelly R.J., and Siegel A. Neurokinin-1 expression and co-localization with glutamate and GABA in the hypothalamus of the cat. Brain Res Mol Brain Res 71 (1999) 149-158
183. Zhang G., Wang L., Liu H., and Zhang J. Substance P promotes sleep in the ventrolateral preoptic area of rats. Brain Res 1028 (2004) 225-232
184. Zhou Q., Kindlundh A.M., Hallberg M., and Nyberg F. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal. Peptides 25 (2004) 1951-1957
185. Zhu X., Robertson J.T., Sacks H.S., Dohan F.C., Tseng J.L., and Desiderio D.M. Opioid and tachykinin neuropeptides in prolactin-secreting human pituitary adenomas. Peptides 16 (1995) 1097-1107